• More 2012 Big Ideas

    Wired | Wired magazine has 25 big ideas for 2012--everything from wireless cars to predicting Facebook's next move to sousveillance. In life sciences, the predictions center around epigenetics and microfluidics.

     

    Jan 5, 2012
  • Predictions for Supercomputing 2012

    Bio-IT World | Guest Commentary | As we welcome 2012, it’s becoming increasingly clear that we are entering a new golden age of high performance computing (HPC) that will drive progress and growth in many other fields. The reason for this is profound: the capabilities of the world’s largest computers running in research facilities, laboratories, and educational institutions, have crossed an important threshold, and we are moving from the information age to the “knowledge age.” With that, here are my ten predictions for high performance computing in the coming year. 

    Jan 4, 2012
  • Texas Genomic Medicine Institute Comes Under Scrutiny

    The Eagle | Six years after Texas Governor Rick Perry created the Texas Institute for Genomic Medicine (TIGM) with a $50 million grant promising to attract thousands of new jobs, the institute employs just nine people.

    Jan 3, 2012
  • Eric Lander: Bravery and Optimism

    New York Times | Eric Lander's Ph.D. in mathematics has taken a back seat to his career in molecular biology, medicine, and genomics as the founding director of the Broad Institute, science advisor to President Obama, and PI. His success can be attributed to two characteristics, says an old friend: bravery combined with optimism.

    Jan 2, 2012
  • 2012 Predictions for Biotech and Medicine

    Forbes | It's the season for soothsaying, and Forbes' Matthew Herper has a few predictions for biotech and medicine. Among them: super-expensive drugs, a tough environment for medical devices, and the stalling of health information technology. Cheery 

    Dec 30, 2011
  • The Perfect Pair: Drugs and Companion Diagnostics

    New York Times | More and more often, the FDA is requiring personalized drugs to have companion diagnostic tests associated with them before approval. The trend has prompted some awkward partnerships in drug discovery.

    Dec 28, 2011
  • Mayo Clinic Plans to Sequence Patients' Genomes for Personalized Medicine

    The Guardian | The Mayo Clinic will launch a pilot study early next year to sequence the genomes of thousands of volunteers in a landmark project to personalize their medical care by allowing doctors to prescribe more effective drugs and other therapies.

    Dec 28, 2011
  • Korean Researchers Identify Gene Fusion Linked to Lung Cancer

    Bio-IT World | Researchers in South Korea have identified a previously unknown gene fusion event that could explain a significant proportion of lung cancer cases in never-smokers, and might serve as a target for new therapies. The results were published online today in Genome Research

    Dec 22, 2011
  • BGI Uses GPU-Accelerated Genomics

    HPC Wire | BGI is using GPU-accelerated computing to process its genomics data. Thanks to NVIDIA GPUs , BGI is able to sequence 6 trillion base pairs per day and have a stored database totaling 20 PB.

    Dec 21, 2011
  • Should Journals Describe How Scientists Made a Killer Flu?

    TIME | This week, the U.S. government did an unprecedented thing by asking two premier research journals, Nature and Sciencenot to publish the details of Dutch experiments on a genetically engineered, highly tranmissible H5N1 virus, for fear that the information could fall into the wrong hands and be used to create a bioweapon.

    Dec 21, 2011
  • Genomics Gift Guide: Neanderthal Test

    Discovery Magazine | 23andMe is offering a Neanderthal genomic test this holiday season to help identify what percentage of your genome comes frm Neanderthal ancestors. 

    Dec 20, 2011
  • CDISC and IMI Sign Standards Agreement

    Bio-IT World  | The Innovative Medicines Initiative Joint Undertaking (IMI) and the Clinical Data Interchange Standards Consortium (CDISC) have signed an agreement and initiated activities to enhance the use of information gathered for the purpose of developing safer, more effective innovative medicines for patients.    

     

    Dec 19, 2011
  • Microsoft's Evolution

    Wired | Of course Microsft is a cloud company, says Kurt DelBene, but the question keeps coming up. The software giant acknowledges the move to the cloud--and has cloud products to prove it--but still believes its customers need and value desktop and server software. 

    Dec 14, 2011
  • Speeding Up Cancer Trials

    Bio-IT World | The Multiple Myeloma Research Consortium (MMRC) has been able to accelerate the clinical trials process by making improvements to trial start-up and enrollment as well as patient accrual for oncology clinical trials run through the Consortium. MMRC presented the data yesterday in an oral presentation at the American Society of Hematology (ASH) Annual Meeting. 

    Dec 14, 2011
  • Assemblathon I Offers Lessons in Complex Genome Assembly

    Bio-IT World | The recently published results of the first round of the Assemblathon, while demonstrating the relative quality of the usual suspects in de novo genome assembly (Broad Institute, Sanger Institute, BGI), offer several important lessons in tackling such projects, according to co-organizer Ian Korf.

    Dec 13, 2011
  • Leading Japanese Genomics Researcher Heading to Chicago

    The Daily Yomiuri | Tokyo University's Yusuke Nakamura, arguably the leading genomics researcher in Japan, is stepping down as head of the office promoting medical innovation to take up a new position at the University of Chicago next April, where he will focus on cancer drug discovery.

    Dec 13, 2011
  • Best Practices 2012: Early Deadline Approaching

    Bio-IT World | The early bird deadline for the 2012 Best Practices competition is this Friday. Since 2003, Bio-IT World's Best Practices competition has been recognizing outstanding examples of technology and strategic innovation initiatives across the drug discovery enterprise. 

    Dec 11, 2011
  • Cancer Researchers Migrate En Masse from Dana Farber to MD Anderson

    Boston Globe | MD Anderson Cancer Center has lured 55 scientists away from the Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute after Ron DePinho, the founding director of the Belfer Institute, was chosen as president of MD Anderson.

    Dec 12, 2011
  • Virus-Like Nanoparticles for Gene Therapy

    R&D Magazine | Yale researchers have developed a nanopartical that can mimic a virus and insert a gene into a diseased cell to either kill or repair it. The technique, published Dec. 4 online in Nature Materials, is based on a novel family of polymers.

    Dec 8, 2011
  • Elsevier Acquires Ariadne Genomics

    Bio-IT World | Elsevier, the Dutch publishing giant, has acquired Ariadne Genomics, a software provider of pathway analysis tools and semantic technologies for life science researchers, based in Rockville, MD 

    Dec 8, 2011